230 related articles for article (PubMed ID: 25555283)
21. Ranolazine (Ranexa) in the treatment of chronic stable angina.
Aslam S; Gray D
Adv Ther; 2010 Apr; 27(4):193-201. PubMed ID: 20449698
[TBL] [Abstract][Full Text] [Related]
22. Ranolazine for the management of coronary artery disease.
Cheng JW
Clin Ther; 2006 Dec; 28(12):1996-2007. PubMed ID: 17296457
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapy for coronary microvascular dysfunction.
Ong P; Athanasiadis A; Sechtem U
Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):65-71. PubMed ID: 27533969
[TBL] [Abstract][Full Text] [Related]
24. Anti-ischemic and pleiotropic effects of ranolazine in chronic coronary syndromes.
Manolis A; Kallistratos M; Poulimenos L; Thomopoulos C
Am J Med Sci; 2024 Mar; 367(3):155-159. PubMed ID: 38072070
[TBL] [Abstract][Full Text] [Related]
25. Different definition of microvascular angina.
Suzuki H
Eur J Clin Invest; 2015 Dec; 45(12):1360-6. PubMed ID: 26480027
[TBL] [Abstract][Full Text] [Related]
26. [Current management of stable ischemic heart disease].
Escobar C; Divisón JA
Semergen; 2017; 43(1):57-58. PubMed ID: 27084462
[No Abstract] [Full Text] [Related]
27. Use of Ranolazine for the Treatment of Coronary Microvascular Dysfunction.
Sharp RP; Patatanian E; Sirajuddin R
Am J Cardiovasc Drugs; 2021 Sep; 21(5):513-521. PubMed ID: 33438139
[TBL] [Abstract][Full Text] [Related]
28. Ranolazine: A Contemporary Review.
Rayner-Hartley E; Sedlak T
J Am Heart Assoc; 2016 Mar; 5(3):e003196. PubMed ID: 26979079
[No Abstract] [Full Text] [Related]
29. Ranolazine: an anti-anginal drug with further therapeutic potential.
Reffelmann T; Kloner RA
Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):319-29. PubMed ID: 20222810
[TBL] [Abstract][Full Text] [Related]
30. Ranolazine reduces repolarization heterogeneity in symptomatic patients with diabetes and non-flow-limiting coronary artery stenosis.
Evaristo E; Stocco FG; Shah NR; Cheezum MK; Hainer J; Foster C; Nearing BD; Di Carli M; Verrier RL
Ann Noninvasive Electrocardiol; 2018 Jan; 23(1):. PubMed ID: 28653394
[TBL] [Abstract][Full Text] [Related]
31. Ranolazine reduces angina frequency and severity and improves quality of life: Observational study in patients with chronic angina under ranolazine treatment in Greece (OSCAR-GR).
Alexopoulos D; Kochiadakis G; Afthonidis D; Barbetseas J; Kelembekoglou P; Limberi S; Spanos A; Triantafyllidis G
Int J Cardiol; 2016 Feb; 205():111-116. PubMed ID: 26730841
[TBL] [Abstract][Full Text] [Related]
32. Persistent thebesian vessels involving the right and left ventricles leading to coronary steal phenomena and ischemia.
Khoueiry G; Baydoun H; Abi Rafeh N; McCord D; Olkovky Y
Congenit Heart Dis; 2014; 9(2):E61-5. PubMed ID: 23663401
[TBL] [Abstract][Full Text] [Related]
33. Ranolazine: a new option in the management of chronic stable angina.
Dobesh PP; Trujillo TC
Pharmacotherapy; 2007 Dec; 27(12):1659-76. PubMed ID: 18041887
[TBL] [Abstract][Full Text] [Related]
34. Ranolazine (Roche Bioscience).
Jones R
IDrugs; 1999 Dec; 2(12):1353-62. PubMed ID: 16113967
[TBL] [Abstract][Full Text] [Related]
35. Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.
Banerjee K; Ghosh RK; Kamatam S; Banerjee A; Gupta A
Int J Cardiol; 2017 Jan; 227():556-564. PubMed ID: 27838121
[TBL] [Abstract][Full Text] [Related]
36. Ranolazine for improving coronary microvascular function in patients with nonobstructive coronary artery disease: a systematic review and meta-analysis with a trial sequential analysis of randomized controlled trials.
Ling H; Fu S; Xu M; Wang B; Li B; Li Y; Liu X; Zhang X; Wang Q; Li A; Liu M
Quant Imaging Med Surg; 2024 Feb; 14(2):1451-1465. PubMed ID: 38415135
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Skene A; McCabe CH; Braunwald E;
Am Heart J; 2006 Jun; 151(6):1186.e1-9. PubMed ID: 16781216
[TBL] [Abstract][Full Text] [Related]
38. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
39. Role of ranolazine in angina, heart failure, arrhythmias, and diabetes.
Sossalla S; Maier LS
Pharmacol Ther; 2012 Mar; 133(3):311-23. PubMed ID: 22133843
[TBL] [Abstract][Full Text] [Related]
40. Microvascular angina (Cardiac Syndrome X) from a historical overview, epidemiology, pathophysiology to treatment recommendations - a minireview.
Jarczewski J; Jarczewska A; Boryczko A; Poniatowski A; Furgała A; Surdacki A; Gil K
Folia Med Cracov; 2021 Sep; 61(3):95-114. PubMed ID: 34882667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
